Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Cancer Stem Cell Therapy Market: Insights and Competitive Analysis 2025 –2032Cancer Stem Cell Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the Cancer Stem Cell Therapy Market CAGR Value The global cancer stem cell therapy market size was valued at USD 1.41 billion in 2025 and is expected to reach USD 2.94 billion by 2033, at a CAGR of 9.65% during the forecast period...0 Comentários 0 Compartilhamentos 749 Visualizações 0 Anterior
-
Cancer Stem Cell Therapy Market: Trends, Forecast, and Competitive Landscape 2025 –2032Executive Summary Cancer Stem Cell Therapy Market Size and Share Forecast CAGR Value The global cancer stem cell therapy market size was valued at USD 1.41 billion in 2025 and is expected to reach USD 2.94 billion by 2033, at a CAGR of 9.65% during the forecast period Cancer Stem Cell Therapy Market research report brings into focus the key market...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Global gene therapy for ovarian cancer market growth outlook with 15.8% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global gene therapy for ovarian cancer market was valued at USD 423.7 million in 2024 and is projected to reach USD 1.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 2025-2031. Gene therapy represents a revolutionary treatment paradigm for ovarian cancer, leveraging...0 Comentários 0 Compartilhamentos 283 Visualizações 0 Anterior
-
Global gene therapy for ovarian cancer market growth outlook with 15.8% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global gene therapy for ovarian cancer market was valued at USD 423.7 million in 2024 and is projected to reach USD 1.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 2025-2031. Gene therapy represents a revolutionary treatment paradigm for ovarian cancer, leveraging...0 Comentários 0 Compartilhamentos 266 Visualizações 0 Anterior
-
Global Prostate Cancer Diagnosis and Therapy Market: 4.8% CAGR to Reach USD 23.5 Billion by 2032According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...0 Comentários 0 Compartilhamentos 186 Visualizações 0 Anterior
-
Global Prostate Cancer Diagnosis and Therapy Market: 4.8% CAGR to Reach USD 23.5 Billion by 2032According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...0 Comentários 0 Compartilhamentos 189 Visualizações 0 Anterior
-
Global Prostate Cancer Diagnosis and Therapy Market: 4.8% CAGR to Reach USD 23.5 Billion by 2032According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...0 Comentários 0 Compartilhamentos 197 Visualizações 0 Anterior
-
Hadron Therapy Market Outlook 2025–2031 | Emerging Cancer Treatment Innovations & 14.3% CAGRThe Hadron Therapy involves the use of particle accelerators to generate beams that can penetrate tumors and release energy at a specific depth. This controlled energy delivery makes it suitable for treating complex cancers. Hadron Therapy Market Overview The Hadron Therapy Market size is expected to reach US$ 4.97 Billion by 2031. The market is anticipated to register a CAGR of 14.3%...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Prostate Cancer Treatment Market Trends: Advancements in Targeted Therapy, Radioligand Therapy, and Precision MedicineThe global Prostate Cancer Treatment Market is witnessing significant growth due to the increasing prevalence of prostate cancer, advancements in precision medicine, rising healthcare expenditure, and the growing adoption of innovative treatment approaches. According to The Insight PArtners, the prostate cancer treatment market size is projected to grow from US$ 19.07 billion in 2022 to US$...0 Comentários 0 Compartilhamentos 215 Visualizações 0 Anterior
-
What Are the Latest Innovations in Cell Cycle Inhibitors Market for Cancer Therapy?Cell Cycle Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the Cell Cycle Inhibitors Market CAGR Value Cell Cycle Inhibitors Market report, businesses can acquire details about market drivers and market restraints which help them to guess about reducing or growing the production of particular product. It also arranges for...0 Comentários 0 Compartilhamentos 214 Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 8KB Visualizações 0 Anterior
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comentários 0 Compartilhamentos 5KB Visualizações 0 Anterior
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior1
-
Chromatography Instrumentation Market Scope and Growth Analysis by 2034The Chromatography instrumentation has become an essential component in modern analytical science, enabling precise separation, identification, and quantification of chemical compounds across multiple industries. Its application spans pharmaceuticals, biotechnology, environmental monitoring, and food safety testing, where accuracy and compliance are critical. The increasing complexity of...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior1
-
Cytokine Market Future Outlook and Investment OpportunitiesThe growing focus on immunology, targeted therapies, and advanced biologics is significantly driving the expansion of the cytokine industry worldwide. Cytokines play a vital role in regulating immune responses, inflammation, and cell signaling, making them essential in the treatment of cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. Increasing investments in...0 Comentários 0 Compartilhamentos 640 Visualizações 0 Anterior
-
Estramustine Phosphate Sodium Market Dynamics and Opportunities 2031Estramustine Phosphate Sodium is an oncology drug primarily indicated for the treatment of metastatic or advanced prostate cancer. It integrates estrogenic components with cytotoxic activity to inhibit cancer cell proliferation. By targeting tumor cell division pathways, it supports disease control in patients requiring specialized therapeutic interventions. Market Overview The Estramustine...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior1
Páginas impulsionada